1. Home
  2. GBIO vs ADUR Comparison

GBIO vs ADUR Comparison

Compare GBIO & ADUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • ADUR
  • Stock Information
  • Founded
  • GBIO 2016
  • ADUR 2011
  • Country
  • GBIO United States
  • ADUR Canada
  • Employees
  • GBIO N/A
  • ADUR 6
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • ADUR
  • Sector
  • GBIO Health Care
  • ADUR
  • Exchange
  • GBIO Nasdaq
  • ADUR NYSE
  • Market Cap
  • GBIO 165.5M
  • ADUR 154.9M
  • IPO Year
  • GBIO 2020
  • ADUR N/A
  • Fundamental
  • Price
  • GBIO $1.37
  • ADUR $5.50
  • Analyst Decision
  • GBIO Strong Buy
  • ADUR
  • Analyst Count
  • GBIO 2
  • ADUR 0
  • Target Price
  • GBIO $7.50
  • ADUR N/A
  • AVG Volume (30 Days)
  • GBIO 179.9K
  • ADUR 126.5K
  • Earning Date
  • GBIO 11-06-2024
  • ADUR 01-01-0001
  • Dividend Yield
  • GBIO N/A
  • ADUR N/A
  • EPS Growth
  • GBIO N/A
  • ADUR N/A
  • EPS
  • GBIO N/A
  • ADUR N/A
  • Revenue
  • GBIO $18,582,000.00
  • ADUR $247,485.00
  • Revenue This Year
  • GBIO $188.06
  • ADUR N/A
  • Revenue Next Year
  • GBIO N/A
  • ADUR N/A
  • P/E Ratio
  • GBIO N/A
  • ADUR N/A
  • Revenue Growth
  • GBIO 514.08
  • ADUR 98.59
  • 52 Week Low
  • GBIO $1.10
  • ADUR $1.34
  • 52 Week High
  • GBIO $4.65
  • ADUR $7.00
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 26.45
  • ADUR N/A
  • Support Level
  • GBIO $1.24
  • ADUR N/A
  • Resistance Level
  • GBIO $2.57
  • ADUR N/A
  • Average True Range (ATR)
  • GBIO 0.21
  • ADUR 0.00
  • MACD
  • GBIO -0.07
  • ADUR 0.00
  • Stochastic Oscillator
  • GBIO 9.77
  • ADUR 0.00

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About ADUR ADURO CLEAN TECHNOLOGIES INC

Aduro Clean Technologies Inc is a developer of patented water-based technologies to chemically recycle plastics and transform heavy crude and renewable oils into feedstocks and higher-value fuels. The company's technology activates unique properties of water in a chemistry platform that operates at relatively low temperatures and costs.

Share on Social Networks: